Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
McMillan ShakespeareASX:MMS -1.00%78 3-Year EBITDA Growth Rate is 16.50% as of Dec. 2025, which is 28% above its 10-year median of 12.90. GuruFocus rates ASX:MMS with a GF Score™ of 78/100 and a GF Value™ of A$24.70 (Modestly Undervalued). The stock has 13 warning signs investors should review. Among 863 Business Services companies, McMillan Shakespeare ranks better than 67.56% on this metric.
During the past 12 months, McMillan Shakespeare's average EBITDA Per Share Growth Rate was 10.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 16.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 2.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of McMillan Shakespeare was 73.70% per year. The lowest was -15.10% per year. And the median was 12.90% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
McMillan Shakespeare 3-Year EBITDA Growth Rate Related Terms
ASX:MMS vs KFY, RHI, TNET: 3-Year EBITDA Growth Rate Comparison
For the Staffing & Employment Services subindustry, McMillan Shakespeare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McMillan Shakespeare 3-Year EBITDA Growth Rate vs Business Services Industry
For the Business Services industry and Industrials sector, McMillan Shakespeare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where McMillan Shakespeare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 16.50% mean?
McMillan Shakespeare (ASX:MMS) has a 3-Year EBITDA Growth Rate of 16.50% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for McMillan Shakespeare and its competitors. This is 28% above median its historical median of 12.90. According to the industry distribution chart, McMillan Shakespeare ranks #280 out of 863 companies in the Business Services industry, placing it in the top 32.4%.
Is McMillan Shakespeare's 3-Year EBITDA Growth Rate too high?
McMillan Shakespeare's current 3-Year EBITDA Growth Rate of 16.50% is 28% above median its 10-year median of 12.90. The Business Services industry median 3-Year EBITDA Growth Rate is 8.10. McMillan Shakespeare's value of 16.50% is 103.7% above this industry median. Based on the distribution chart, McMillan Shakespeare ranks #280 out of 863 companies in the Business Services industry, which is above the industry midpoint. Overall, McMillan Shakespeare has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does McMillan Shakespeare's 3-Year EBITDA Growth Rate compare to KFY and RHI?
According to the Business Services industry distribution chart, McMillan Shakespeare ranks #280 out of 863 companies for 3-Year EBITDA Growth Rate. This puts McMillan Shakespeare in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.10. McMillan Shakespeare's value of 16.50% is 103.7% above this benchmark. While the company's 10-year median is 12.90 vs. the industry median of 8.10, McMillan Shakespeare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Business Services company?
The median 3-Year EBITDA Growth Rate among Business Services companies is 8.10, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. McMillan Shakespeare's current 3-Year EBITDA Growth Rate of 16.50% is 103.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for McMillan Shakespeare and its competitors. For the Business Services industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. McMillan Shakespeare's current 3-Year EBITDA Growth Rate is 16.50%, which is 28% above median its own 10-year median of 12.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McMillan Shakespeare stock overvalued right now?
Based on GuruFocus' analysis, McMillan Shakespeare (ASX:MMS) is currently considered Modestly Undervalued. The stock's GF Value™ is A$24.70, compared to a current price of A$19.85 — trading 19.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 16.50%, which is 28% above median its 10-year median of 12.90 and 103.7% above the Business Services industry median of 8.10. McMillan Shakespeare's overall GF Score™ is 78/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For McMillan Shakespeare (ASX:MMS), the current 3-Year EBITDA Growth Rate is 16.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is McMillan Shakespeare (ASX:MMS) Overvalued in 2026?
Based on GuruFocus' analysis, McMillan Shakespeare stock appears to be undervalued.
The current stock price of A$19.85 is trading 19.6% below its estimated GF Value™ of A$24.70.
GuruFocus considers McMillan Shakespeare to be Modestly Undervalued.
Key valuation signals for ASX:MMS:
3-Year EBITDA Growth Rate: 16.50% (28% above median its 10-year median of 12.90)
GF Value™: A$24.70 vs. price of A$19.85 (19.6% below fair value)
Industry Position: 103.7% above the Business Services median (#280 of 863)
No single metric tells the full story. See the ASX:MMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
McMillan Shakespeare is a provider of salary packaging, novated leasing, disability plan management and support co-ordination, and fleet management services. It actively works to cross-sell its products to clients, for example, selling its salary packaging services to its fleet management customers in Australia and New Zealand. McMillan dominates Australia's salary packaging market together with Smartgroup (also covered by Morningstar), and is also a large provider of novated leasing services by volumes—together with Smartgroup and SG Fleet. The group has three operating segments: group remuneration services, asset management services, and plan and support services. Most of the group's revenue is generated from the group remuneration services segment.
78GF Score
Get the complete analysis for ASX:MMS
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MMS has been successfully added to your 
